The University of Michigan has developed a groundbreaking gastrointestinal device to help diagnose and predict treatment outcomes for chronic constipation. FDA-approved in 2024, the device offers a more efficient solution for primary care doctors, reducing unnecessary referrals and costs. The project was made possible through the MTRAC Life Sciences Innovation Hub, which played a key role in turning this breakthrough concept into a market-ready solution—discover how this innovative approach is reshaping healthcare.
